These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21883368)

  • 1. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN; Dyck R; Weenig RH; Comfere NI
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN; Plaza JA
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
    Morgan MB; Purohit C; Anglin TR
    Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA; Brill LB; Patterson JW; Wick MR
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
    Dotto JE; Glusac EJ
    J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas.
    Hall JM; Saenger JS; Fadare O
    Int J Clin Exp Pathol; 2008 Mar; 1(6):524-30. PubMed ID: 18787630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
    Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
    J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
    Clarke LE; Frauenhoffer E; Fox E; Neves R; Bruggeman RD; Helm KF
    J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma.
    Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW
    J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AFX: what we now know.
    McCalmont TH
    J Cutan Pathol; 2011 Nov; 38(11):853-6. PubMed ID: 21955311
    [No Abstract]   [Full Text] [Related]  

  • 15. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
    Miller K; Goodlad JR; Brenn T
    Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphic spindle cell dermal neoplasm with dot-like keratin reactivity: keratin-positive AFX or carcinoma?
    Ellis R; Chase E; Barland A; Rajpara A; Fraga GR
    J Cutan Pathol; 2015 Nov; 42(11):847-52. PubMed ID: 26041010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of CD163 in cutaneous spindle cell lesions.
    Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
    J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies.
    Henderson SA; Torres-Cabala CA; Curry JL; Bassett RL; Ivan D; Prieto VG; Tetzlaff MT
    Am J Surg Pathol; 2014 Aug; 38(8):1102-10. PubMed ID: 25029117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma.
    Wagoner J; Keehn C; Morgan MB
    Am J Dermatopathol; 2007 Dec; 29(6):555-8. PubMed ID: 18032951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
    Sigal AC; Keenan M; Lazova R
    Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.